By Sahil Pandey Sept 24 (Reuters) - Acadia Pharmaceuticals said on Thursday its experimental drug for psychosis associated with Alzheimer's disease missed the main goal of a mid-stage study, sending ...

The Lindsay Clancy case has renewed debate over postpartum mental health care, including screening, home visits, treatment, ...

Emerging studies show how AI-associated psychosis evolves as AI chatbots are found to reinforce users’ delusional beliefs ...

Postpartum psychosis is a rare, clinically dramatic disorder typically beginning within a few weeks of delivery. Recent ...

Acadia hopes to become one of the first companies to secure approval for a therapy specifically indicated for ADP.

The prosecution rested its case Monday in the Lindsay Clancy trial, and the defense has since begun calling witnesses to address her state of mind when she killed her three children.

Author Jodi Picoult shares her take on trauma and postpartum psychosis as explored in her latest novel, "Hollow Bones." ...

Last week, a judge declared a mistrial in the murder case of Lindsay Clancy, leading the public to wonder: What really went ...

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.

While Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy body ...

Prosecutors are still weighing whether to retry Lindsay Clancy, the mother accused of killing her three young children, after ...